About Lindus Health
Lindus Health is a next-generation contract research organization (CRO) that fundamentally reimagines clinical trial delivery through integrated technology and accountability. Founded to address the chronic delays and cost overruns plaguing traditional CROs, Lindus operates through a single AI-assisted trial operating system called Citrus that unifies patient recruitment, study operations, and clinical data management. The company's distinctive approach centers on performance-based commercial models with milestone-based payments, aligning financial incentives with sponsor timelines and budgets. Lindus has demonstrated exceptional performance, with 82% of trials completing enrollment on or ahead of schedule compared to the 20% industry average. The company provides full-service clinical trial capabilities spanning study design through database lock, with expertise across cardiometabolic, respiratory, psychiatry, dermatology, women's health, and diagnostics therapeutic areas. Operating with over 160 full-time staff across the US, UK, and Europe with integrated APAC partnerships, Lindus serves biotech and pharmaceutical companies seeking predictable, accountable trial execution. The company's integrated model eliminates the fragmentation typical of traditional CROs by maintaining one team accountable for each program from protocol design through completion, with real-time visibility into enrollment performance and data completeness. With annual team turnover under 12% (less than half the industry average), Lindus has established itself as a technology-forward, operationally excellent partner for sponsors requiring confidence and control over their clinical studies.
Mission & Story
Mission
Powering biology's century. Built on one accountable system.
Founding Story
Founded by Meri Beckwith and Michael Young after experiencing CRO failures from different perspectives. Beckwith, a former life sciences venture capital investor, repeatedly saw CROs fail to deliver trials on time and budget, then participated in a COVID-19 vaccine trial where he witnessed fragmented technology and operational problems firsthand. Young, a former Special Adviser to the UK Prime Minister, saw during the pandemic how trial delivery depended on fragmented, outdated infrastructure and became convinced the industry needed a fundamentally different operating model.
Clinical Focus
Medical conditions and clinical areas addressed by Lindus Health.
Who It Serves
Milestones & Awards
Recent Milestones
Strategic partnership with Quotient Sciences announced December 2025; finalist for Best Contract Research Organization 2025; finalist for AI Innovation Challenge 2025; Outstanding Patient Recruitment & Retention award 2025
Awards & Recognition
Outstanding Patient Recruitment & Retention 2025; Best Contract Research Organization Finalist 2025; AI Innovation Challenge Finalist 2025
Key Partnerships
.png)
Company Details
- Headquarters
- United Kingdom
- Employees
- 51-200
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.